Differential antiviral activities of respiratory syncytial virus (RSV) inhibitors in human airway epithelium

Objectives We report the use of reconstituted 3D human airway epithelium cells (HuAECs) of bronchial origin in an air–liquid interface to study respiratory syncytial virus (RSV) infection and to assess the efficacy of RSV inhibitors in (pre-)clinical development.